Latest News Archive

Please select Category, Year, and then Month to display items

Graduates to celebrate their achievements at 2019 December Graduations

13 November 2019 | Story Xolisa Mnukwa | Photo Sonia Small

During the upcoming graduation ceremonies, the University of the Free State (UFS) will confer a number of qualifications on the Bloemfontein Campus on 9, 10 and 11 December 2019 in the Faculties of Education; the Humanities; Law; Theology and Religion; Economic and Management Sciences; Natural and Agricultural Sciences; and Health Sciences. 517 National Professional Diplomas and Advanced Certificates will be awarded to students graduating from the UFS South Campus University Access Programme.

An additional 147 master’s and doctoral degrees will be conferred in the Faculties of Education, Economic and Management Sciences, Health Sciences, the Humanities, Law, and Theology and Religion.

For more information about the upcoming graduation ceremonies and events, visit the UFS graduation ceremonies page.

Graduates can read through the Bloemfontein Graduations: Preparing for Graduations - Frequently Asked Questions (FAQs), which contain the necessary information for graduates to note during the graduation processions.

Graduation ceremonies for the different faculties will take place on the following dates:

9 Dec 2019
14:30: South Campus: Open Distance Learning
Certificates and diplomas

10 Dec 2019
09:00: Faculties of Education, the Humanities, Law, and Theology and Religion
All certificates, diplomas, bachelor’s degrees, and honours degrees

14:30: Faculties of Economic and Management Sciences and Natural and Agricultural Sciences
All certificates, diplomas, bachelor’s degrees, and honours degrees

11 Dec 2019
09:00: Faculty of Health Sciences
All certificates, diplomas, bachelor’s degrees, and honours degrees

14:30: All Faculties
Master's and doctoral qualifications

News Archive

New research informs improved treatment of brain inflammation

2017-10-13

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish

Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology.

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs.

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept